Search
Now showing items 1-7 of 7
Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent
(Univerisyt of Nairobi, 2009-12)
Bacterial vaginosis (BV) is a recurrent condition that is associated with a range of negative outcomes, including the acquisition of human immunodeficiency virus and other sexually transmitted diseases, preterm births, and ...
CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
(2/6/2009)
Background: Clinical laboratory reference intervals have not been established in many African countries, and non-local
intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African ...
CLSI-derived hematology and biochemistry reference intervals for healthy adults in Eastern and Southern Africa
(2009)
Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. ...
CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
(2009)
Clinical laboratory reference intervals have not been established in many African countries, and non-local
intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among African participants. ...
Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya
(2009)
Access to antiretroviral therapy (ART) is increasing in resource-limited settings (RLS) and can
successfully reduce HIV-related morbidity and mortality. However, virologic failure and
development of viral drug resistance ...
Pregnancy rates among female participants in phase I and phase IIA AIDS vaccine clinical trials in Kenya
(2009-09)
Background: Female participants in AIDS candidate vaccine clinical trials must agree to use effective contraception to be enrolled into the studies, and for a specified period after vaccination, since the candidate vaccines’ ...
European and developing countries clinical trials partnership (EDCTP):
(2009)
European and Developing Countries Clinical Trials Partnership (EDCTP) was
founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union
(EU) member states, Norway, Switzerland, and ...